Skip to Content
Trade options on Composer. Earn up to $200 in cash rebates!Get Started.T&Cs apply.
Symphonies
Exothermic R&D Squeeze
Today’s Change
—

A symphony is an automated trading strategy — Learn more about symphonies here

About

Two-sleeve, tactical equity strategy. If BE/QS/IONQ pop today, it holds them; otherwise it rotates into recent winners in housing/REITs/income, Asia tech/semis, or biotech/health. Equal split across sleeves; steadier picks get larger weights.
NutHow it works
Splits the portfolio into two halves. Half A reacts to Bloom Energy (BE) and QuantumScape (QS): if either is up today, it holds it (BE half also adds ERY, an ETF that rises when energy stocks fall); otherwise it buys recent winners in real estate/homebuilders/income and Asia tech/semis. Half B reacts to IonQ (IONQ): if up, hold it; else buy the strongest biotech/health name. Half A sizes steadier picks larger. It changes only when signals flip.
CheckmarkValue prop
A tactical two-sleeve momentum strategy that seeks short-term squeezes in BE/QS/IONQ and rotates winners in related baskets. Inverse-vol weighting adds beta diversification. Note: OOS performance trails SPY; best as a tactical sleeve, not core.
1M
3M
6M
YTD
1Y
3Y
Max
www.composer.trade
Performance
Compared to selected benchmarks
AlphaBetaR2R
SPY
0.321.190.240.49
Performance Metrics
Cumulative ReturnAnnualized ReturnTrailing 1M ReturnTrailing 3M ReturnSharpe Ratio
SPY
67.83%25.37%1.75%5.97%1.51
Exothermic R&D Squeeze
238.57%70.34%3.55%13.17%1.58
Initial Investment
$10,000.00
Final Value
$33,857.13
Regulatory Fees
$205.12
Total Slippage
$1,160.42
Invest in this strategy
OOS Start Date
Jan 13, 2026
Trading Setting
Threshold 0.25%
Type
Stocks
Category
Equities, momentum rotation, clean energy, real estate/homebuilders, asia tech/semis, biotech/healthcare, leveraged etfs
Tickers in this symphonyThis symphony trades 26 assets in total
Ticker
Type
ALNY
Alnylam Pharmaceuticals, Inc.
Stocks
ARKG
ARK Genomic Revolution ETF
Stocks
BALI
iShares U.S. Large Cap Premium Income Active ETF
Stocks
BE
Bloom Energy Corporation
Stocks
BEAM
Beam Therapeutics Inc. Common Stock
Stocks
BSX
Boston Scientific Corp.
Stocks
CRSP
CRISPR Therapeutics AG
Stocks
ERY
Direxion Daily Energy Bear 2X Shares
Stocks
EWT
iShares MSCI Taiwan ETF
Stocks
EWY
iShares MSCI South Korea ETF
Stocks

FAQ

A Composer symphony is an automated trading strategy that executes trades based on parameters of your choice. Some symphonies are similar to holding one ETF in normal conditions and rotating to a different ETF when market conditions shift, for example a 5% drop in the S&P 500, while others use complex rules with dozens of triggers. However, complex doesn’t always mean better. A simple, well-structured symphony can be just as effective as an intricate one. Learn more about how symphonies work here.

"Exothermic R&D Squeeze" is currently performing the same as yesterday today. Performance updates in real time during market hours.

"Exothermic R&D Squeeze" is currently allocated toTOL, KORU, JNJandEWY. Holdings automatically adjust as market conditions change based on the strategy's rules.

Year-to-date, "Exothermic R&D Squeeze" has returned 9.62%. You can adjust the performance chart above to view returns across different time horizons.

The maximum drawdown for "Exothermic R&D Squeeze" is 7.64%. The maximum drawdown measures the largest peak-to-trough decline. It's an important metric to evaluate risk and the strategy's behavior during market stress.

To invest in "Exothermic R&D Squeeze", simply click the Invest button on this page. You'll need to open an account with Composer if you don't have one yet, then you can start investing. Composer will automatically execute the trades for you based on the strategy's rules. Composer also supports trading individual stocks, ETFs, and options.